Canada · Delayed Price · Currency is CAD Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of CAD 10.85 million. The enterprise value is 10.11 million.
| Market Cap | 10.85M |
| Enterprise Value | 10.11M |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medicure has 10.44 million shares outstanding.
| Current Share Class | 10.44M |
| Shares Outstanding | 10.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 26.21% |
| Owned by Institutions (%) | 0.62% |
| Float | 5.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 10.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.04 |
| Quick Ratio | 0.70 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -64.71 |
Financial Efficiency
Return on equity (ROE) is -41.57% and return on invested capital (ROIC) is -60.29%.
| Return on Equity (ROE) | -41.57% |
| Return on Assets (ROA) | -15.52% |
| Return on Invested Capital (ROIC) | -60.29% |
| Return on Capital Employed (ROCE) | -50.71% |
| Weighted Average Cost of Capital (WACC) | 10.06% |
| Revenue Per Employee | 824,158 |
| Profits Per Employee | -179,184 |
| Employee Count | 38 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 5.32 |
Taxes
In the past 12 months, Medicure has paid 179,000 in taxes.
| Income Tax | 179,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.11% in the last 52 weeks. The beta is 1.06, so Medicure's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -11.11% |
| 50-Day Moving Average | 1.13 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 44.42 |
| Average Volume (20 Days) | 4,201 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of CAD 31.32 million and -6.81 million in losses. Loss per share was -0.65.
| Revenue | 31.32M |
| Gross Profit | 12.43M |
| Operating Income | -6.60M |
| Pretax Income | -6.63M |
| Net Income | -6.81M |
| EBITDA | -4.88M |
| EBIT | -6.60M |
| Loss Per Share | -0.65 |
Balance Sheet
The company has 1.54 million in cash and 803,000 in debt, with a net cash position of 739,000 or 0.07 per share.
| Cash & Cash Equivalents | 1.54M |
| Total Debt | 803,000 |
| Net Cash | 739,000 |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 12.67M |
| Book Value Per Share | 1.21 |
| Working Capital | 392,000 |
Cash Flow
| Operating Cash Flow | -3.04M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.72M |
| Net Borrowing | -438,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 39.68%, with operating and profit margins of -21.07% and -21.74%.
| Gross Margin | 39.68% |
| Operating Margin | -21.07% |
| Pretax Margin | -21.17% |
| Profit Margin | -21.74% |
| EBITDA Margin | -15.59% |
| EBIT Margin | -21.07% |
| FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -62.73% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
| Last Split Date | Nov 2, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -3.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.37 |
| Piotroski F-Score | 2 |